학술논문
Neoadjuvant Dual Checkpoint Inhibitors vs Anti-PD1 Therapy in High-Risk Resectable Melanoma: A Pooled Analysis.
Document Type
Article
Author
Source
JAMA Oncology; May2024, Vol. 10 Issue 5, p612-620, 9p
Subject
Language
ISSN
23742437